Skip to main content
Charlotte Teunissen

Charlotte Teunissen

Professor of Neurochemistry and Head of the Neurochemistry Laboratory at Amsterdam UMC, a leading researcher on fluid biomarkers for neurodegenerative diseases.

Sep 9, 2026

10:13
So is real-world testing already moving faster than the guidance can keep up with and what would help close that gap?
10:20
Well, I would say that there are also positive things ongoing, that testing is already being used in the right context.
10:28
In patients who have cognitive decline, that's objective.
10:33
So there is cognitive impairment.
10:36
Using high quality tests and also that there is interpretation of the test results done by healthcare professionals that are experts in cognitive problems.
10:47
So there are positive things going on.
10:49
But the use of the direct-to-consumer test, that goes a little bit outside the control.
12:31
And can you expand a little bit more on what the most urgent unmet need is for fluid biomarker development?

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.